Is a complete MYGN research report available?

No complete published report is available for Myriad Genetics, Inc. (MYGN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Myriad Genetics, Inc. (MYGN)

NASDAQ: MYGN · USD

$6.61

+0.32 (+5.1%)· Recorded snapshot

Market cap	632.2M
Revenue (ttm)	806.6M
Net income (ttm)	-112.6M
EPS (ttm)	-$1.20
Shares out	95.6M
Volume	2,003,558
Beta	1.64

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 806.6M
Net income (ttm): -112.6M
EPS (ttm): -$1.20
Market cap: 632.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Aanhouden

Metric	Value
Amount currency	USD
CIK code	0000899923
Company name	Myriad Genetics, Inc.
Country	United States
Country code	US
CUSIP number	62855J104
Earnings date	2026-11-04
Earnings time	amc
Employees	2,700
Employees change	100
Employees growth	3.85%
Enterprise value	$727.5M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1991
In index	RUSSELL2000
Industry	Diagnostics & Research
IPO date	1995-10-05
Is primary listing	Yes
Is SPAC	No
ISIN number	US62855J1043
Last 10-K release date	2026-02-24
Last earnings date	2026-07-30
Last refreshed	2026-10-28
Last stock split date	2009-03-26
Last stock split type	Forward
Market cap	$632.2M
Market cap category	Small-Cap
Next earnings date	2026-11-04
Options	Yes
Price	$6.61
Price currency	USD
Sector	Healthcare
SIC code	2835
Stock price date	2026-10-28
Symbol	MYGN
U.S. state	Utah
Website	https://www.myriad.com

Metric

Value

Amount currency

USD

CIK code

0000899923

Company name

Myriad Genetics, Inc.

Country

United States

Country code

CUSIP number

62855J104

Earnings date

2026-11-04

Earnings time

amc

Employees

2,700

Employees change

100

Employees growth

3.85%

Enterprise value

$727.5M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1991

In index

RUSSELL2000

Industry

Diagnostics & Research

IPO date

1995-10-05

Is primary listing

Yes

Is SPAC

ISIN number

US62855J1043

Last 10-K release date

2026-02-24

Last earnings date

2026-07-30

Last refreshed

2026-10-28

Last stock split date

2009-03-26

Last stock split type

Forward

Market cap

$632.2M

Market cap category

Small-Cap

Next earnings date

2026-11-04

Options

Yes

Price

$6.61

Price currency

USD

Sector

Healthcare

SIC code

2835

Stock price date

2026-10-28

Symbol

MYGN

U.S. state

Utah

Website

https://www.myriad.com

Metric	Value
Earnings yield	-18.2%
EV/Sales	0.89x
FCF / EV yield	-1.02%
FCF yield	-1.18%
Forward EV/Sales	0.89x
Forward P/S	0.77x
Industry forward P/E	30.87x
Industry P/E	50.24x
P/B ratio	1.98x
P/OCF ratio	80.37x
P/S ratio	0.77x
Price / tangible book value	5.25x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-18.2%

EV/Sales

0.89x

FCF / EV yield

-1.02%

FCF yield

-1.18%

Forward EV/Sales

0.89x

Forward P/S

0.77x

Industry forward P/E

30.87x

Industry P/E

50.24x

P/B ratio

1.98x

P/OCF ratio

80.37x

P/S ratio

0.77x

Price / tangible book value

5.25x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
EBIT margin	-11.22%
EBITDA margin	-5%
Gross margin	68.83%
Operating margin	-11.22%
Pretax margin	-13.86%
Profit margin	-13.96%
Profit per employee	$-41,704
Revenue per employee	$298,741
ROA	-8.59%
ROA (5Y)	-5.91%
ROCE	-17.81%
ROE	-32.54%
ROE (5Y)	-26.44%
ROIC	-21.97%
ROIC (5Y)	-13.93%
SBC / revenue	3.56%
Tax / revenue	0.1%

Metric

Value

EBIT margin

-11.22%

EBITDA margin

-5%

Gross margin

68.83%

Operating margin

-11.22%

Pretax margin

-13.86%

Profit margin

-13.96%

Profit per employee

$-41,704

Revenue per employee

$298,741

ROA

-8.59%

ROA (5Y)

-5.91%

ROCE

-17.81%

ROE

-32.54%

ROE (5Y)

-26.44%

ROIC

-21.97%

ROIC (5Y)

-13.93%

SBC / revenue

3.56%

Tax / revenue

0.1%

Metric	Value
EPS growth quarters	1
EPS growth years	0
Gross profit growth	-5.35%
Gross profit growth (Q)	-16.34%
Gross profit growth 3Y	5.15%
Gross profit growth 5Y	3.52%
Net income growth quarters	1
Net income growth years	0
OCF growth 10Y	-26.45%
Revenue growth	-3.16%
Revenue growth (Q)	-10.51%
Revenue growth (QoQ)	-4.84%
Revenue growth 10Y	0.86%
Revenue growth 3Y	4.89%
Revenue growth 5Y	4.02%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-5.35%

Gross profit growth (Q)

-16.34%

Gross profit growth 3Y

5.15%

Gross profit growth 5Y

3.52%

Net income growth quarters

Net income growth years

OCF growth 10Y

-26.45%

Revenue growth

-3.16%

Revenue growth (Q)

-10.51%

Revenue growth (QoQ)

-4.84%

Revenue growth 10Y

0.86%

Revenue growth 3Y

4.89%

Revenue growth 5Y

4.02%

Revenue growth years

Metric	Value
Capital expenditures	$-15M
Depreciation and amortization	$50.2M
EBIT	$-90.5M
EBITDA	$-40.3M
EPS	$-1.20
FCF per share	$-0.08
Financing cash flow	$47.2M
Free cash flow	$-7.3M
Free cash flow minus SBC	$-36M
Gross profit	$555.2M
Income taxes	$800,000
Investing cash flow	$-21.9M
Net borrowing	$64.9M
Net cash flow	$33.1M
Net income	$-112.6M
Operating cash flow minus SBC	$-21M
Operating income	$-90.5M
Revenue	$806.6M
Stock-based compensation	$28.7M

Metric

Value

Capital expenditures

$-15M

Depreciation and amortization

$50.2M

EBIT

$-90.5M

EBITDA

$-40.3M

EPS

$-1.20

FCF per share

$-0.08

Financing cash flow

$47.2M

Free cash flow

$-7.3M

Free cash flow minus SBC

$-36M

Gross profit

$555.2M

Income taxes

$800,000

Investing cash flow

$-21.9M

Net borrowing

$64.9M

Net cash flow

$33.1M

Net income

$-112.6M

Operating cash flow minus SBC

$-21M

Operating income

$-90.5M

Revenue

$806.6M

Stock-based compensation

$28.7M

Metric	Value
Altman Z-Score	-0.58
Book value per share	$3.18
Debt / equity	0.69
Goodwill	$47.1M
Interest coverage	-5.52
Long-term assets	$349.9M
Long-term liabilities	$204.3M
Net cash (debt)	$-95.3M
Net cash / market cap	-15.4%
Net debt / equity	0.31
Piotroski F-Score	4
Property, plant and equipment	$158.9M
Shareholders' equity	$303.9M
Tangible book value	$117.8M
Tangible book value per share	$1.23
Total assets	$638.9M
Total cash	$115.2M
Total debt	$210.5M
Total liabilities	$335M
WACC	11.48%

Metric

Value

Altman Z-Score

-0.58

Book value per share

$3.18

Debt / equity

0.69

Goodwill

$47.1M

Interest coverage

-5.52

Long-term assets

$349.9M

Long-term liabilities

$204.3M

Net cash (debt)

$-95.3M

Net cash / market cap

-15.4%

Net debt / equity

0.31

Piotroski F-Score

Property, plant and equipment

$158.9M

Shareholders' equity

$303.9M

Tangible book value

$117.8M

Tangible book value per share

$1.23

Total assets

$638.9M

Total cash

$115.2M

Total debt

$210.5M

Total liabilities

$335M

WACC

11.48%

Metric	Value
Asset turnover	1.23
Current assets	$289M
Current liabilities	$130.7M
Current ratio	2.21
Inventory turnover	8.48
Net working capital	$50.4M
Quick ratio	1.72
Working capital	$158.3M
Working capital turnover	6.65

Metric

Value

Asset turnover

1.23

Current assets

$289M

Current liabilities

$130.7M

Current ratio

2.21

Inventory turnover

8.48

Net working capital

$50.4M

Quick ratio

1.72

Working capital

$158.3M

Working capital turnover

6.65

Metric	Value
Buyback yield / dilution	-2.46%
Dividend yield	0%
Shareholder yield	-2.46%

Metric

Value

Buyback yield / dilution

-2.46%

Dividend yield

Shareholder yield

-2.46%

Metric	Value
10Y price change	-66.35%
10Y return CAGR	-10.32%
10Y total return	-66.35%
150-day SMA	$4.44
15Y price change	-69.62%
15Y return CAGR	-7.64%
15Y total return	-69.62%
1D price change	5.09%
1M price change	58.51%
1M total return	58.51%
1W price change	18.67%
1W total return	18.67%
1Y price change	-18.4%
1Y return CAGR	-18.41%
1Y total return	-18.4%
20-day SMA	$4.84
200-day SMA	$4.60
20Y price change	-50.82%
20Y return CAGR	-3.26%
20Y total return	-48.43%
3M price change	21.28%
3M total return	21.28%
3Y price change	-52.48%
3Y return CAGR	-21.96%
3Y total return	-52.48%
50-day SMA	$4.08
50-day SMA vs 200-day SMA	50under200
52-week high	$8.38
52-week high date	2025-11-03
52-week low	$2.74
52-week low date	2026-08-03
5Y price change	-78.43%
5Y return CAGR	-26.42%
5Y total return	-78.43%
6M price change	36.85%
6M total return	36.85%
All-time high	$69.00
All-time high date	2000-11-06
All-time low	$1.44
All-time low date	1998-08-31
Average true range (ATR)	$0.37
Average volume	3.2M
Beta (1Y)	-0.03
Beta (2Y)	1.2
Beta (5Y)	1.64
Change from 52-week high	-21.12%
Change from 52-week low	141.24%
Change from all-time high	-90.42%
Change from all-time low	359.67%
Change from open	6.27%
Day's gap	-1.11%
Dollar volume	$13.2M
High price	$6.64
Low price	$6.21
Monthly RSI	44.89
Open price	$6.22
Position in 52-week range	93.02%
Premarket change	0.32%
Premarket close	$6.29
Premarket price	$6.31
Premarket volume	2.3K
Previous close	$6.29
Price vs 150-day SMA	48.91%
Price vs 20-day SMA	36.51%
Price vs 200-day SMA	43.57%
Price vs 50-day SMA	61.97%
Relative volume	0.64
RSI	80.92
Sharpe ratio	0.2
Sharpe ratio (3Y)	-0.01
Sharpe ratio (5Y)	-0.17
Sortino ratio	0.33
Sortino ratio (3Y)	0.05
Sortino ratio (5Y)	-0.15
Volume	2M
Weekly RSI	64.35
YTD price change	7.48%
YTD total return	7.48%

Metric

Value

10Y price change

-66.35%

10Y return CAGR

-10.32%

10Y total return

-66.35%

150-day SMA

$4.44

15Y price change

-69.62%

15Y return CAGR

-7.64%

15Y total return

-69.62%

1D price change

5.09%

1M price change

58.51%

1M total return

58.51%

1W price change

18.67%

1W total return

18.67%

1Y price change

-18.4%

1Y return CAGR

-18.41%

1Y total return

-18.4%

20-day SMA

$4.84

200-day SMA

$4.60

20Y price change

-50.82%

20Y return CAGR

-3.26%

20Y total return

-48.43%

3M price change

21.28%

3M total return

21.28%

3Y price change

-52.48%

3Y return CAGR

-21.96%

3Y total return

-52.48%

50-day SMA

$4.08

50-day SMA vs 200-day SMA

50under200

52-week high

$8.38

52-week high date

2025-11-03

52-week low

$2.74

52-week low date

2026-08-03

5Y price change

-78.43%

5Y return CAGR

-26.42%

5Y total return

-78.43%

6M price change

36.85%

6M total return

36.85%

All-time high

$69.00

All-time high date

2000-11-06

All-time low

$1.44

All-time low date

1998-08-31

Average true range (ATR)

$0.37

Average volume

3.2M

Beta (1Y)

-0.03

Beta (2Y)

1.2

Beta (5Y)

1.64

Change from 52-week high

-21.12%

Change from 52-week low

141.24%

Change from all-time high

-90.42%

Change from all-time low

359.67%

Change from open

6.27%

Day's gap

-1.11%

Dollar volume

$13.2M

High price

$6.64

Low price

$6.21

Monthly RSI

44.89

Open price

$6.22

Position in 52-week range

93.02%

Premarket change

0.32%

Premarket close

$6.29

Premarket price

$6.31

Premarket volume

2.3K

Previous close

$6.29

Price vs 150-day SMA

48.91%

Price vs 20-day SMA

36.51%

Price vs 200-day SMA

43.57%

Price vs 50-day SMA

61.97%

Relative volume

0.64

RSI

80.92

Sharpe ratio

0.2

Sharpe ratio (3Y)

-0.01

Sharpe ratio (5Y)

-0.17

Sortino ratio

0.33

Sortino ratio (3Y)

0.05

Sortino ratio (5Y)

-0.15

Volume

Weekly RSI

64.35

YTD price change

7.48%

YTD total return

7.48%

Metric	Value
Float	79.3M
Float percentage	82.89%
Shares change (QoQ)	1.17%
Shares change (YoY)	2.46%
Shares held by insiders	4.17%
Shares held by institutions	83.39%
Shares outstanding	95.6M
Short % of float	10.78%
Short % of shares	8.93%
Short ratio	4.1 days

Metric

Value

Float

79.3M

Float percentage

82.89%

Shares change (QoQ)

1.17%

Shares change (YoY)

2.46%

Shares held by insiders

4.17%

Shares held by institutions

83.39%

Shares outstanding

95.6M

Short % of float

10.78%

Short % of shares

8.93%

Short ratio

4.1 days

Myriad Genetics, Inc. (MYGN)

Price

Financial snapshot

Fair-value bridge

Latest news · MYGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MYGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MYGN

Frequently asked questions